Insulin Pump for KidsMade for Childhood
Tandem Diabetes Care automated insulin delivery systems are #1 in clinical outcomes!1
Time in Closed-Loop
Automation2
Time in Range Overnight
For all age groups3
Time in Range
Based on real-world data4*
With an insulin pump that predicts and helps prevent highs and lows.
Tandem Mobi System
This insulin pump can be worn almost anywhere,† giving you more options for how you manage your diabetes. It’s powered by Control-IQ+ technology and is controllable with a compatible, personal smartphone.
See the Features #TeamTandem Parents Know and Love
The Only System with AutoBolus
Better A1c results, even for kids or teens who occasionally miss meal boluses.5
Better Sleep for the Whole Family
The only system with a dedicated Sleep Activity. Data showed a 90% overnight time in range for real-world users.3
Small On-Body Footprint
More than 30 mix-and-match infusion set options for convenience, choice, and discretion.
Personal Profiles
Create up to six Personal Profiles to account for changing insulin needs (growth spurts, hormones, etc.).
What People Are Saying
Hear from parents how Tandem automated delivery systems have made life better for the whole family.
Going from shots to the Tandem Mobi has been life-changing. The accuracy and control we have now has been great.
Ginny
Mother to Ben, diagnosed 2024
Shannon
Mother to Raelynn, diagnosed 2022
Markquetto
Mother to Syncere, diagnosed 2023
Maria
Mother to Jarim, diagnosed 2020
Individual symptoms, situations, circumstances, and results may vary.
What's next?
Whether you're ready to get a Tandem insulin pump, or looking to check insurance coverage, you’ll find everything you need here.
Try Our PumpsFree Virtual Demos
Test drive the easy-to-use interfaces of either Tandem Mobi or t:slim X2 automated insulin delivery systems, with no obligation.
*With optimized correction factor based on “rule of less than 1600.”
† Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin.
‡ CGM sold separately.
References
Note: Some studies were conducted using a t:slim X2 insulin pump with Control-IQ technology and a Dexcom G6 CGM sensor.
1. Seagrove Partners HCP Perspectives (Devices), September 2025 Insulin Delivery Section N=120
2. Mueller L, et al. Diabetes. 2020;69(Supplement_1):95-LB.
3. Breton MD, Kovatchev BP. Diabetes Technol Ther. 2021;23(9):601-608.
4. Messer LH, Breton M. Diabetes Technol Ther. 2023;25(12):877-882.
5. Akturk HK, et al. Diabetes Technol Ther. 2022;24(10):779-783.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.